eremy Brownstein, MD, Associate Professor of Radiation Oncology at The Ohio State University Comprehensive Cancer Center (IMAGE)
Caption
“After surgery, patients with non‑small cell lung cancer remain at high risk for recurrence despite advances in systemic therapy,” said study co-chair Jeremy Brownstein, MD, Associate Professor of Radiation Oncology at The Ohio State University Comprehensive Cancer Center. “Our trial will rigorously evaluate whether modern, involved‑station post‑operative radiation therapy added to standard-of-care post-surgical treatments can improve disease control with minimal side effects. The results will help clarify the role of post‑operative radiation in this challenging patient population.”
Credit
The Ohio State University Comprehensive Cancer Center
Usage Restrictions
none
License
Original content